Walleye Trading
ARIA

Walleye Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Walleye Trading’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,100
Closed -$18K – 5864
2015
Q2 		$18K Buy
2,100
+1,700
+425% +$15K ﹤0.01% 4046
2015
Q1 		$3K Sell
400
-3,900
-91% -$28.8K ﹤0.01% 3916
2014
Q4 		$30K Sell
4,300
-1,200
-22% -$7.5K ﹤0.01% 3487
2014
Q3 		$31K Sell
5,500
-700
-11% -$4.09K ﹤0.01% 3385
2014
Q2 		$40 Buy
6,200
+5,700
+1,140% +$39.2K ﹤0.01% 2973
2014
Q1 		$4 Hold
500
– – ﹤0.01% 3381
2013
Q4 		$4K Buy
500
+300
+150% +$1.62K ﹤0.01% 3491
2013
Q3 		$4K Buy
+200
New +$3.88K ﹤0.01% 2795

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Walleye Trading's ARIA Position: Q3 2016 in Review

Walleye Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 500 shares — an estimated $4K sold.

Walleye Trading first reported a position in ARIA in Q2 2013 and held it in 7 quarters. The position peaked at $48K in Q3 2013. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Walleye Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Walleye Trading sold 500 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $4K.
  • Walleye Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
  • Walleye Trading's Ariad Pharmaceuticals Inc position peaked at $48K in Q3 2013.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.